Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
Patients who have obstructive sleep apnea (OSA) frequently stop breathing while they sleep.
They often develop high blood pressure. We are not sure what drug is best to treat the high
blood pressure. This study will give the patients guanfacine or hydrochlorothiazide (HCTZ)
for 6 weeks after 2 weeks of placebo. The blood pressure response will be evaluated by 24
hour monitoring.